Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,135
+$10,650 QoQ
Shares Held
250
+4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#644
of 768 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Basecamp Wealth Advisors LLC holds $657,399 across 21 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
24,573 | $356,062 | |
| 2 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
4,416 | $89,114 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
250 | $42,135 | |
| 4 | HLN |
Haleon plc
|
4,079 | $38,057 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,787 | $28,645 | |
| 6 | VTRS |
Viatris Inc
|
1,536 | $24,391 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
41 | $22,215 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
511 | $17,716 |
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,135 | 250 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $31,485 | 239 | Shares | Sole | 2026-06-24 | |
| 2025-12-31 | $4,964 | 35 | Shares | Sole | 2026-06-24 | |
| No filing history on record for this holder in this stock. | ||||||